164 related articles for article (PubMed ID: 25380939)
1. Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report.
Kozlowska-Skrzypczak M; Bembnista E; Kubiak A; Matuszak P; Schneider A; Komarnicki M
Transplant Proc; 2014 Oct; 46(8):2873-6. PubMed ID: 25380939
[TBL] [Abstract][Full Text] [Related]
2. Autologous transplant: microbial contamination of hematopoietic stem cell products.
Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
[TBL] [Abstract][Full Text] [Related]
3. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
Dal MS; Tekgündüz E; Çakar MK; Kaya AH; Namdaroğu S; Batgi H; Bekdemir F; Uncu Ulu B; Yiğenoğlu TN; Kılınç A; İskender D; Uğur B; Koçubaba Ş; İskender G; Altuntaş F
Transfus Apher Sci; 2016 Aug; 55(1):125-8. PubMed ID: 27184293
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation.
Nifong TP; Ehmann WC; Mierski JA; Domen RE; Rybka WB
Arch Pathol Lab Med; 2003 Jan; 127(1):e19-21. PubMed ID: 12562288
[TBL] [Abstract][Full Text] [Related]
5. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
6. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
7. Reducing Microbial Contamination in Hematopoietic Stem Cell Products and Quality Improvement Strategy: Retrospective Analysis of 1996-2021 Data.
Ko YK; Lee JK; Park HK; Han AK; Mun SK; Park HJ; Choung HK; Kim SM; Choi KM; Lee NY; Cho D; Kim DW; Kang ES
Ann Lab Med; 2023 Sep; 43(5):477-484. PubMed ID: 37080749
[TBL] [Abstract][Full Text] [Related]
8. Impact of microbial contamination of haematopoietic stem cells on post-transplant outcomes: A retrospective study from tertiary care centre in India.
Garg V; Kodan P; Pushpam D; Bakhshi S; Kumar L; Sharma A; Gupta G; Gupta N
Transfus Med; 2021 Oct; 31(5):377-382. PubMed ID: 34396610
[TBL] [Abstract][Full Text] [Related]
9. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
[TBL] [Abstract][Full Text] [Related]
10. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
[TBL] [Abstract][Full Text] [Related]
11. Microbial contamination of peripheral blood stem cell collections.
Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
[TBL] [Abstract][Full Text] [Related]
12. Microbial contamination of harvested bone marrow and peripheral blood.
Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
[TBL] [Abstract][Full Text] [Related]
13. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
[TBL] [Abstract][Full Text] [Related]
14. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
15. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
16. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for microbial contamination of peripheral blood stem cell products.
Donmez A; Aydemir S; Arik B; Tunger A; Cilli F; Orman M; Tombuloglu M
Transfusion; 2012 Apr; 52(4):777-81. PubMed ID: 21981571
[TBL] [Abstract][Full Text] [Related]
18. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
Cheah PL; Ong CW; Crispin P
Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
[TBL] [Abstract][Full Text] [Related]
19. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
20. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
